Sign In
Buy EVH
$3.78
-0.180 (-4.55%)
At Close: Jun 03, 2026
Evolent Health (EVH) Moves to Buy: Rationale Behind the Upgrade
01:32pm, Thursday, 05'th Oct 2023
Evolent Health (EVH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
A First Evaluation On Evolent Health
03:16pm, Wednesday, 04'th Oct 2023
Evolent Health, Inc., is a mid-cap solutions provider in the healthcare space that made a major acquisition late last year. The stock is down some 30% from recent highs despite impressive sales growth
Evolent Health to Participate in Upcoming Conferences
05:00pm, Tuesday, 08'th Aug 2023
WASHINGTON , Aug. 8, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make h
Evolent Health, Inc. (EVH) Q2 2023 Earnings Call Transcript
11:25pm, Wednesday, 02'nd Aug 2023
Evolent Health, Inc. (NYSE:EVH ) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Seth Frank – Vice President-Investor Relations Seth Blackley – Chief Executive Offi
Evolent Health: Business Economics Still Appealing, Reiterate Buy
06:43pm, Wednesday, 19'th Jul 2023
Evolent Health's sales and profitability are creeping back above pre-pandemic levels. The company's recent acquisitions have added incremental value, with revenues up 44% YoY and adjusted EBITDA up 94
Evolent Health, Inc. (EVH) Q1 2023 Earnings Call Transcript
10:50pm, Wednesday, 03'rd May 2023
Evolent Health, Inc. (NYSE:EVH ) Q1 2023 Results Conference Call May 3, 2023 5:00 PM ET Company Participants Seth Frank - VP, IR Seth Blackley - CEO John Johnson - CFO Conference Call Participants San
Evolent Health (EVH) Beats Q1 Earnings Estimates
08:32pm, Wednesday, 03'rd May 2023
Evolent Health (EVH) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.12 per share a year ago.
Fast Pitch: Essex Investments's co-CEO sees growth in this health care name
07:19pm, Thursday, 20'th Apr 2023
Nancy Prial, Essex Investments Management co-chief executive officer & senior portfolio manager, on Evolent Health with CNBC's Melissa Lee and the Fast Money traders.
Evolent Health to Participate in Upcoming Conferences
08:00am, Friday, 03'rd Mar 2023
WASHINGTON , March 3, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced t
Evolent Health, Inc. (EVH) Q4 2022 Earnings Call Transcript
11:29pm, Wednesday, 22'nd Feb 2023
Evolent Health, Inc. (NYSE:EVH ) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Offi
Evolent Health (EVH) Surpasses Q4 Earnings and Revenue Estimates
08:19pm, Wednesday, 22'nd Feb 2023
Evolent Health (EVH) delivered earnings and revenue surprises of 66.67% and 2.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
10:39am, Wednesday, 15'th Feb 2023
Evolent Health is a high growth stock that has rewarded shareholders with tremendous upside. The company has been reinvesting heavily into its growth initiatives at high rates of return.
Evolent Health, Inc. to Release Fourth Quarter Financial Results and Host Conference Call on Wednesday, February 22, 2023
05:00pm, Tuesday, 31'st Jan 2023
WASHINGTON , Jan. 31, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced i
Evolent Health to Participate in Upcoming Conferences
04:15pm, Tuesday, 29'th Nov 2022
WASHINGTON , Nov. 29, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced t
Evolent Health: A Bit Complex, But Interesting
05:05am, Monday, 21'st Nov 2022
Evolent Health announced its next deal, intensifying its relationship with Centene in the meantime. The deal is a bit complicated but has potential, as underlying sales growth has been accelerating.
